Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation

International Journal of Hematology

Volumn 94, Issue 6, 2011, Pages 561-566

  Kawano, Noriaki ^a   Okuda, Shinya ^b   Yoshida, Shuro ^a   Kugimiya, Hiroko ^a   Ito, Masaki ^a   Horikawa, Nagako ^a   Chosa, Nobuaki ^a   Hisakata, Tomoko ^a   Fukudome, Tomoko ^a   Sakurai, Ryoko ^a   Yamashita, Kiyoshi ^a   Ueda, Akira ^a   Kanda, Yoshinobu ^b  

^a MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Additional bcr abl transcript; Allogeneic bone marrow stem cell transplantation; Chronic myelogenous leukemia; Imatinib; Lymphoid blastic crisis

Indexed keywords

ASPARAGINASE; BCR ABL PROTEIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; IDARUBICIN; IMATINIB; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DRUG MEGADOSE; FEMALE; GENETIC TRANSCRIPTION; HLA MATCHING; HUMAN; LEG PAIN; PHENOTYPE; POLYMERASE CHAIN REACTION; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLAST CRISIS; COMBINED MODALITY THERAPY; FEMALE; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PHILADELPHIA CHROMOSOME; PIPERAZINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PYRIMIDINES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84355161599     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0956-y     Document Type: Article

References (16)

1. BJ Druker 2008 Translation of the Philadelphia chromosome into therapy for CML Blood 112 4808 4817 19064740 10.1182/blood-2008-07-077958 1:CAS:528:DC%2BD1cXhsFWms7%2FP
2. BJ Druker F Guilhot SG O'Brien IRIS Investigators, et al. 2006 Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N Engl J Med 355 2408 2417 17151364 10.1056/NEJMoa062867 1:CAS:528:DC%2BD28Xht12ntrzM (Pubitemid 44903745)
3. TP Hughes A Hochhaus S Branford IRIS Investigators, et al. 2010 Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS) Blood 116 3758 3765 20679528 10.1182/blood-2010-03-273979 1:CAS:528:DC%2BC3cXhsFahsLfF
4. M Baccarani J Cortes F Pane European LeukemiaNet, et al. 2009 Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet J Clin Oncol 27 6041 6051 19884523 10.1200/JCO.2009.25.0779 1:CAS:528:DC%2BC3cXhtVWisLY%3D
5. M Tanaka Y Yamazaki M Hattori K Tsushita M Utsumi S Yoshida 1996 The dual expression of minor and major bcr/abl chimeric mRNA in blast crisis of chronic myelogenous leukemia Leuk Res 20 575 580 8795691 10.1016/0145-2126(96)00010-0 1:CAS:528:DyaK28XlvFKru7w%3D (Pubitemid 26285340)
6. MC Bene G Castoldi W Knapp, et al. 1995 Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL) Leukemia 9 1783 1786 7564526 1:STN:280:DyaK28%2Fhtl2rsQ%3D%3D
7. BJ Druker CL Sawyers H Kantarjian, et al. 2001 Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 344 1038 1042 11287973 10.1056/NEJM200104053441402 1:CAS:528:DC%2BD3MXivFGnu7o%3D (Pubitemid 32267973)
8. E Jabbour J Cortes FP Santos, et al. 2011 Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations Blood 117 3641 3647 21156844 10.1182/blood-2010-08-302679 1:CAS:528:DC%2BC3MXkslagur8%3D
9. The Japan Society for Hematopoietic Cell Transplantation. The Japan Society for Hematopoietic Cell Transplantation Annual report of Nationwide Survey 2007. 41, 2007.
10. A Gratwohl J Hermans JM Goldman, et al. 1998 Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Lancet 352 1087 1092 9798583 10.1016/S0140-6736(98) 03030-X 1:STN:280:DyaK1M%2Fht12htQ%3D%3D (Pubitemid 28448513)
11. A Gratwohl R Brand J Apperley Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation, et al. 2006 Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Haematologica 91 513 521 16533723
12. M Griesshammer B Heinze A Hellmann, et al. 1996 Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients Ann Hematol 73 225 230 8959940 10.1007/s002770050233 1:STN:280:DyaK2s7hvFWitQ%3D%3D (Pubitemid 26401797)
13. M Griesshammer B Heinze M Bangerter H Heimpel TM Fliedner 1997 Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia J Mol Med 75 836 838 9428614 10.1007/s001090050173 1:STN:280:DyaK1c%2FovVyqsg%3D%3D (Pubitemid 27511559)
14. Ninomiya S, Kanemura N, Tsurumi H, Kasahara S, Hara T, Yamada T, Moriwaki H. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis. Int J Hematol. 2011 Jun;93(6):806-10 (Epub 2011 Apr 27).
15. Klyuchnikov E, Kröger N, Brummendorf TH, Wiedemann B, Zander AR, Bacher U. Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML). Biol Blood Marrow Transplant. 2010;16(3):301-10 (Epub 2009 Sep 8, review).
16. Y Kanda K Izutsu H Hirai H Sakamaki T Iseki Y Kodera, et al. 2004 Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate Leukemia 18 1013 1019 15029208 10.1038/sj.leu.2403343 1:CAS:528:DC%2BD2cXjtlyitL4%3D (Pubitemid 38714628)